Tocilizumab for Severe COVID-19 Pneumonia: Experience from 5 Geriatric Chinese Patients with 6 Months Follow-up

OBJECTIVE: To enable physicians to understand the efficacy and safety of Tocilizumab (TCZ) in patients with severe coronavirus disease-2019 (COVID-19) METHODS: We respectively reviewed the clinical records, laboratory results, and chest computed tomography (CT) scans of 5 geriatric patients with sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Aihua, Chen, Zhe, Cheng, Yongjing, Wang, Xutao, Gao, Ming, Huang, Cibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524772/
https://www.ncbi.nlm.nih.gov/pubmed/36467896
http://dx.doi.org/10.2478/rir-2021-0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524772/
https://www.ncbi.nlm.nih.gov/pubmed/36467896
http://dx.doi.org/10.2478/rir-2021-0009

Ejemplares similares